Fortis Group Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
3,214
+18
+0.6% +$1.57K 0.05% 220
2026
Q1
$273K Buy
3,196
+50
+2% +$4.46K 0.05% 246
2025
Q4
$284K Buy
3,146
+285
+10% +$22.3K 0.05% 244
2025
Q3
$220K Hold
2,861
0.04% 220
2025
Q2
$240K Hold
2,861
0.04% 200
2025
Q1
$268K Hold
2,861
0.05% 168
2024
Q4
$260K Hold
2,861
0.05% 172
2024
Q3
$297K Sell
2,861
-15
-0.5% -$1.53K 0.05% 158
2024
Q2
$279K Buy
2,876
+15
+0.5% +$1.38K 0.06% 156
2024
Q1
$258K Hold
2,861
0.05% 179
2023
Q4
$215K Hold
2,861
0.05% 122
2023
Q3
$215K Hold
2,861
0.07% 115
2023
Q2
$220K Hold
2,861
0.06% 124
2023
Q1
$228K Buy
+2,861
New +$213K 0.07% 114
2020
Q3
$426K Buy
+5,532
New +$422K 0.08% 116

Other funds holding CL

Fortis Group Advisors's CL Position: Q2 2026 in Review

Fortis Group Advisors increased its Colgate-Palmolive (CL) stake by 0.56% in Q2 2026, buying an estimated $1.57K and bringing the position to 3,214 shares worth $295K. The position accounts for 0.05% of the portfolio, ranked #220.

Fortis Group Advisors first reported a position in CL in Q3 2020 and has held it in 15 quarters since. The position peaked at $426K in Q3 2020. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Fortis Group Advisors held 3,214 shares of Colgate-Palmolive worth $295K as of Q2 2026.
  • Fortis Group Advisors bought 18 Colgate-Palmolive shares in Q2 2026, an estimated $1.57K.
  • Colgate-Palmolive made up 0.05% of Fortis Group Advisors's portfolio in Q2 2026, its #220 holding.
  • Fortis Group Advisors first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 15 quarters since.
  • Fortis Group Advisors's Colgate-Palmolive position peaked at $426K in Q3 2020.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.